Colgate-Palmolive stock holds steady as insider plans $920,000 share sale

Colgate-Palmolive (ISIN US1941621039) stock was quoted at $92.46 at the close on August 24, 2026, up 1.52% for the session and modestly below a fair-value estimate of $95.07 that implies limited undervaluation for the consumer staples group.

On the regulatory side, a recent Form 144 filing shows that a company officer has notified plans to sell 10,000 shares of Colgate-Palmolive common stock with an aggregate market value of $920,477.17 based on the price at the time of the notice. Together with a dividend yield of 2.29% and a payout ratio cited at 55%, the combination of insider activity and steady income profile gives investors fresh data points as of late August 2026.

Insider files planned 10,000 share sale

According to a Form 144 notice summarized in a regulatory-tracking report dated August 24, 2026, Colgate-Palmolive officer Panagiotis Tsourapas has filed to sell 10,000 shares of the company’s common stock on the New York Stock Exchange with Merrill Lynch acting as broker the Form 144 summary.

The filing states that the 10,000 shares covered by the notice carry an aggregate market value of $920,477.17 based on the reference price in the document, implying a reference price of about $92.05 per share for the planned transaction the officer sale details.

By comparison, a same-day market overview shows Colgate-Palmolive closing at $92.46 on August 24, 2026, which is slightly above the implied reference price in the filing and leaves the stock close to that indicated transaction level the CL quote overview.

Valuation and dividend profile in focus

Recent valuation analysis using a GF Value framework puts a fair-value estimate for Colgate-Palmolive at $95.07 per share, which is 2.7% above the referenced market price of $92.55 used in that assessment the valuation and dividend review.

On that basis, the stock is described as 2.7% undervalued relative to the $95.07 fair-value line, suggesting modest upside potential if the shares were to trade back to the indicated intrinsic value the broader valuation context.

The same assessment highlights a dividend yield of 2.29% for Colgate-Palmolive supported by a payout ratio of 55% and average dividend growth of 3.5% over the past three years the dividend profile summary.

For income-focused investors, those numbers indicate a balance between shareholder distributions and retained earnings, with the 55% payout level leaving room for reinvestment while still providing a mid-single-digit cash yield.

A sector teardown of household products stocks following second-quarter reporting shows Colgate-Palmolive trading at $91.24 at the time of that review, with the stock described as flat since the company reported its latest results the household products Q2 teardown.

Comparing the $91.24 level at that earlier snapshot with the $92.46 close on August 24, 2026, indicates a gain of $1.22 per share, or 1.3%, over the period between the Q2-focused note and the latest closing price.

In valuation terms, that still leaves the share price $2.61 below the $95.07 fair-value estimate today, a gap of 2.7% that frames the current trading range as modestly below intrinsic value on this specific model.

Leadership changes in Asia-Pacific arm

On the corporate side, Colgate-Palmolive has also announced a notable leadership move in its Asia-Pacific marketing organization in August 2026.

An announcement distributed on August 21, 2026, states that Prabha Narasimhan, currently Managing Director and Chief Executive Officer of Colgate-Palmolive (India) Limited, has been elevated to the role of Executive Vice President, Marketing, Asia-Pacific Division, effective at the close of business hours on September 27, 2026 the Narasimhan promotion announcement.

The move underscores the company’s emphasis on leadership continuity and regional marketing expertise in a high-growth geography, while the local listed affiliate in India continues to operate as a key part of the global portfolio.

Separate coverage of CEO changes across major Indian-listed firms notes that the announcement concerning Narasimhan was associated with a 0.5% decline in Colgate-Palmolive India’s share price in the week around the news, illustrating how management transitions can prompt modest short-term share-price reactions even when framed as promotions or strategic moves the CEO changes and stock impact overview.

For global investors in the New York-listed parent, the promotion signals strengthening of the Asia-Pacific marketing bench at Colgate-Palmolive, a region that is typically important for volume growth in oral care and personal-care products.

Representative product: Colgate toothpaste franchise

Colgate-Palmolive’s most recognizable line remains its Colgate-branded toothpaste franchise, which spans cavity protection, whitening, sensitivity relief, and premium sub-brands targeted at consumers worldwide.

Through this flagship oral-care line, the company leverages brand recognition, distribution scale, and continuous product innovation to support market share in both developed and emerging markets.

Colgate-Palmolive stock on the NYSE

Colgate-Palmolive stock trades on the New York Stock Exchange under the ticker CL, with a last regular-session close of $92.46 on August 24, 2026, and a modest discount to a $95.07 intrinsic-value estimate highlighting a combination of income appeal and defensive consumer-staples positioning at current levels.

Fact box

Company: Colgate-Palmolive Co.

ISIN: US1941621039

Ticker: CL

Exchange: NYSE

Price (as of August 24, 2026, 3:59 p.m. ET): $92.46 USD

Market cap: $76.4 billion (as of August 24, 2026)

Sector / Industry: Consumer staples / Household and personal products

Index membership: S&P 500